Skip to content

A study on effectiveness of YOGA based cardiac rehabilitation programme in India and United Kingdom

Effects of a yoga-based cardiac rehabilitation programme (Yoga-CaRe) on cardiovascular health: a clinical trial (India) and mechanistic study (UK) - YOGA-CaRe Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/02/002408
Enrollment
4080
Registered
2012-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Acute Myocardial Infarction Health Condition 2: I219- Acute myocardial infarction, unspecified

Interventions

Intervention1: YOGA based cardiac rehabilitation programme: The intervention being assessed is Yoga-CaRe, a yoga-based cardiac rehabilitation programme, delivered at the hospital in 13 sessions spread

Sponsors

Indian Council of Medical Research
Lead Sponsor
Medical Research Council
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Male and female patients 30 - 80 years old • Patients with first or consequent acute myocardial infarction who survive to hospital discharge. Myocardial infarction will be confirmed by standard definition (symptoms, cardiac enzymes and electrocardiographic changes).28 Those that have undergone a revascularisation procedure during previous or current admission will also be eligible. • Willing and able to attend the complete hospital-based CR programme on their own • Patients who are willing to consent.

Exclusion criteria

Exclusion criteria: • Patients who are not willing to consent.

Design outcomes

Primary

MeasureTime frame
1) The primary outcome measure will be a composite of total mortality, nonfatal myocardial infarction and stroke. 2) The co-primary outcome of quality of life outcome will be assessed by the EuroQol EQ-5D Health-Related Quality of Life (HRQOL)questionnaireTimepoint: 1) At one year. 2) At 12 weeks

Secondary

MeasureTime frame
1) Return to pre-infarct daily activities will be assessed by questionnaire 2) Data on smoking cessation and compliance with medication for secondary prevention will be based on self-reports 3) Cost-effectiveness will be assessed by the EuroQoL methodTimepoint: 1) At 12 week 2) At 12-week 3) At 12 week & 6-monthly

Countries

India, United Kingdom

Contacts

Public ContactDorairaj Prabhakaran

Centre for Chronic Disease Control

dprabhakaran@ccdcindia.org011-26850117

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 27, 2026